Inventor · disambiguated record
Zusheng Xu
Also filed as: XU ZUSHENG
18 granted patents·9 pending applications·6 citations·filing 2012–2024
86Inventor score
Files withSHANGHAI YINGLI PHARM CO LTD15280 BIO INC5GUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD4SHANGHAI CHEMEXPLORER CO LTD1SHANGHAI YINGLI SCIENCE AND TECH CO LTD1
Top patents by PatentIndex Score
27 records- 0184US11078192B2Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2017·Granted Aug 3, 2021·2 cites·21 claims
- 0269US9656996B2Fused heterocyclic compound, preparation method therefor, pharmaceutical composition, and uses thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2014·Granted May 23, 2017·2 cites·15 claims
- 0365US10494378B2Fused ring pyrimidine compound, intermediate, and preparation method, composition and use thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2016·Granted Dec 3, 2019·1 cites·18 claims
- 0462US2025154142A1Thiadiazole-substituted compound, pharmaceutical compositions thereof, and applications thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2024·Application pending·0 cites
- 0559US2025059202A1Crystal form of fused ring derivative, and preparation method therefor and use thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2022·Application pending·0 cites
- 0658US11168072B2Crystal form of morpholino quinazoline compound, preparation method therefor and use thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2019·Granted Nov 9, 2021·0 cites·10 claims
- 0758US2025042891A1Compound containing structure of a heteroaromatic ring, pharmaceutical composition thereof and application thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2023·Application pending·0 cites
- 0857US10611770B2Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2019·Granted Apr 7, 2020·0 cites·19 claims
- 0957US2024425512A1Nitrogen-containing heterocyclic compound, pharmaceutical composition thereof and application thereof280 BIO INC·Filed 2024·Application pending·0 cites
- 1056US10100016B2Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2018·Granted Oct 16, 2018·0 cites·16 claims
- 1156US8980829B2Aryl glycoside compound, preparation method and use thereofXU ZUSHENG·Filed 2012·Granted Mar 17, 2015·1 cites·21 claims
- 1255US2024217947A1Morpholinylquinazoline Compound, Pharmaceutical compositions thereof and Use ThereofSHANGHAI YINGLI PHARM CO LTD·Filed 2022·Application pending·0 cites
- 1354US11505542B2Preparation method for morpholinquinazoline compound and intermediates thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2019·Granted Nov 22, 2022·0 cites·20 claims
- 1453US10259816B2Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereofGUANGZHOU MAXINOVEL PHARMACEUTICALS CO LTD·Filed 2016·Granted Apr 16, 2019·0 cites·19 claims
- 1553US2024158408A1Nitrogen-Containing Heterocyclic Compound, Pharmaceutical Compositions thereof and Use thereof280 BIO INC·Filed 2023·Application pending·0 cites
- 1651US10100015B2Condensed ring derivative, and preparation method, intermediate, pharmaceutical composition and use thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2016·Granted Oct 16, 2018·0 cites·16 claims
- 1751US2023242552A1Nitrogen-Containing Heterocyclic Compound, Preparation Method Therefor and Use Thereof280 BIO INC·Filed 2023·Application pending·0 cites
- 1849US2023391785A1Nitrogen-containing heterocyclic compound, method for preparing same and use of same280 BIO INC·Filed 2022·Application pending·0 cites
- 1948US12275727B2Compound containing structure of a five-membered heteroaromatic ring, pharmaceutical compositions thereof and applications thereof280 BIO INC·Filed 2023·Granted Apr 15, 2025·0 cites·13 claims
- 2045US2022315598A1Oxygen-containing Heterocyclic Compound, Preparation Method Therefor and Use ThereofSHANGHAI YINGLI PHARM CO LTD·Filed 2020·Application pending·0 cites
- 2143US9745321B2Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2014·Granted Aug 29, 2017·0 cites·45 claims
- 2240US11584745B2Aromatic heterocyclic compound, intermediate thereof, preparation method therefor, and pharmaceutical composition and use thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2018·Granted Feb 21, 2023·0 cites·16 claims
- 2339US11447490B2Aromatic heterocyclic substituted olefin compound, preparation method for same, pharmaceutical composition of same, and applications thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2018·Granted Sep 20, 2022·0 cites·14 claims
- 2439US9738603B2Complex of glucose derivative and proline, crystal, preparation method and useSHANGHAI YINGLI PHARM CO LTD·Filed 2013·Granted Aug 22, 2017·0 cites·11 claims
- 2537US11466003B2Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereofSHANGHAI YINGLI PHARM CO LTD·Filed 2017·Granted Oct 11, 2022·0 cites·14 claims
- 2634US9745320B2Five-and-six-membered heterocyclic compound, and preparation method, pharmaceutical composition and use thereofSHANGHAI CHEMEXPLORER CO LTD·Filed 2014·Granted Aug 29, 2017·0 cites·19 claims
- 2734US9499561B2Fused pyrimidine compound, and preparation method, intermediate, composition, and uses thereofSHANGHAI YINGLI SCIENCE AND TECH CO LTD·Filed 2013·Granted Nov 22, 2016·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Zusheng Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →